EBS 8.88 (+7.38%)
US29089Q1058Drug ManufacturersDrug Manufacturers - Specialty & Generic

Emergent BioSolutions (EBS) Financial Metrics

This table shows a selected set of financial data points of Emergent BioSolutions (EBS). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -14.85 0 -0.16 122.88M -0.3 1.02B -257.9M -67.5M -760.5M 111.7M
2022 -4.22 0 -2.8 591.68M -0.07 1.08B -149.9M -31.7M -211.6M 642.6M
2021 4.1 0 10.6 2.33B 0.08 1.64B 96.1M 503.2M 219.5M 576.1M
2020 5.8 0 15.44 4.72B 0.12 1.46B 395M 557.7M 305.8M 621.3M
2019 1.06 0 50.98 2.78B 0.02 1.11B 101.1M 226.5M 54.5M 167.8M
2018 1.22 0 48.6 3.05B 0.04 782.4M -30.3M 153.6M 62.7M 112.2M
2017 1.64 0 28.32 2.34B 0.08 560.87M 153.31M 167.8M 82.59M 178.29M
2016 1.05 0 31.29 1.62B 0.05 488.78M -22.77M 134.32M 51.78M 271.51M
2015 1.33 0 30.07 1.89B 0.06 522.79M -353K 131.63M 62.87M 312.8M
2014 0.8 0 33.94 1.25B 0.05 450.14M 81.65M 93.76M 36.74M 280.5M
2013 0.85 0 27.13 844.83M 0.05 312.75M 54.95M 63.2M 31.14M 179.34M
2012 0.65 0 24.83 584.19M 0.04 281.89M -14.2M 48.65M 23.52M 141.67M
2011 0.64 0 26.49 609.71M 0.04 273.38M -39.43M 48.2M 23.02M 143.9M
2010 1.59 0 14.77 763.39M 0.12 286.17M 77.44M 83.87M 51.7M 169.02M
2009 0.99 0 13.69 426.39M 0.1 234.79M -2.78M 51.12M 31.14M 102.92M
2008 0.68 0 38.45 795.26M 0.07 178.55M -13.5M 37.7M 20.68M 91.47M
2007 0.77 0 6.54 150.1M 0.09 182.92M 11.48M 40.8M 22.94M 105.73M
2006 0.93 0 12.03 274.17M 0.13 152.73M -45.29M 42.73M 22.79M 76.42M
2005 0.69 0 0 0 0.19 130.69M 35.72M 24.66M 15.78M 36.29M
2004 0.56 0 0 0 0.33 83.49M -7.88M 18.47M 11.47M 6.82M
2003 0.22 0 0 0 0.39 55.77M 0 4.45M 4.45M 0
2002 1.75 0 0 0 1.51 78.54M 0 37.13M 36.39M 4.89M
2001 -0.03 0 0 0 0 45.31M 0 -554K -554K 5.85M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.